Bunge's $34 billion Viterra merger stalled by US-China trade rift, Bloomberg reports

Reuters
05-02
UPDATE 3-Bunge's $34 billion Viterra merger stalled by US-China trade rift, Bloomberg reports

Adds Viterra's response in paragraph 2

May 2 (Reuters) - Bunge Global's BG.N $34 billion merger with Glencore-backed GLEN.L Viterra is being stalled by trade tensions between the United States and China, Bloomberg News reported on Friday, citing people familiar with the matter.

"We are in the final stage of regulatory approval. We express our continued gratitude for the constructive dialogue with Chinese government officials throughout the regulatory review process," Bunge and Viterra said in separate emailed responses to Reuters.

The merger was first announced in 2023. If finalized, it will create a global crop trading and processing giant closer in scale to chief rivals Archer-Daniels-Midland ADM.N and Cargill [RIC:RIC:CARG.UL].

Regulatory approval in China is among the last remaining hurdles to the deal's closing.

Bunge has said it has obtained most global approvals required for the merger - which was initially expected to close in mid-2024 - including in the European Union and Canada.

Bunge executives and advisers are growing increasingly concerned that the political rift between the two countries will hold up the process further, according to the report.

Bunge CEO Greg Heckman made several trips to China for discussions with authorities, the Bloomberg report said. It also said Chinese regulators have flagged concerns that the merger would increase industry concentration and potentially impact Beijing's food security interests.

The relevant regulators are conducting a careful compliance review given the deal's significance, according to the report.

(Reporting by Vallari Srivastava in Bengaluru; Editing by Anil D'Silva, Pooja Desai and Tasim Zahid)

((Srivastava.Vallari@thomsonreuters.com;))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10